- Home
- L vs UTHR Comparison
L vs UTHR Comparison
Compare L & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- L
- UTHR
- Stock Information
- Founded
- L 1969
- UTHR 1996
- Country
- L United States
- UTHR United States
- Employees
- L N/A
- UTHR N/A
- Industry
- L Property-Casualty Insurers
- UTHR Biotechnology: Pharmaceutical Preparations
- Sector
- L Finance
- UTHR Health Care
- Exchange
- L Nasdaq
- UTHR Nasdaq
- Market Cap
- L 17.8B
- UTHR 14.4B
- IPO Year
- L N/A
- UTHR 1999
- Fundamental
- Price
- L $85.32
- UTHR $284.73
- Analyst Decision
- L
- UTHR Buy
- Analyst Count
- L 0
- UTHR 12
- Target Price
- L N/A
- UTHR $388.25
- AVG Volume (30 Days)
- L 982.6K
- UTHR 499.4K
- Earning Date
- L 05-05-2025
- UTHR 04-30-2025
- Dividend Yield
- L 0.29%
- UTHR N/A
- EPS Growth
- L 1.91
- UTHR 24.38
- EPS
- L 6.41
- UTHR 24.64
- Revenue
- L $17,510,000,000.00
- UTHR $2,877,400,000.00
- Revenue This Year
- L N/A
- UTHR $11.52
- Revenue Next Year
- L N/A
- UTHR $6.08
- P/E Ratio
- L $13.31
- UTHR $11.56
- Revenue Growth
- L 10.12
- UTHR 23.63
- 52 Week Low
- L $73.15
- UTHR $233.28
- 52 Week High
- L $92.42
- UTHR $417.82
- Technical
- Relative Strength Index (RSI)
- L 46.81
- UTHR 37.49
- Support Level
- L $84.64
- UTHR $266.98
- Resistance Level
- L $87.25
- UTHR $288.54
- Average True Range (ATR)
- L 2.93
- UTHR 14.43
- MACD
- L -0.32
- UTHR -0.15
- Stochastic Oscillator
- L 47.17
- UTHR 38.23
About L Loews Corporation
Loews Corp is a holding company that is supported by a variety of businesses. Its majority revenue generating subsidiary is CNA Financial Corporation, a property and casualty insurance company. CNA's services include risk management, information services, and warranty and claims administration. Loews also maintains an operation of offshore oil and gas drilling rigs through Diamond Offshore Drilling, Inc. The company engages in the transportation and storage of natural gas and natural gas liquids and gathering and processing of natural gas through Boardwalk Pipeline Partners, LP. Loews also operates a chain of hotels.
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.